Dr Macaya Douoguih, head of clinical development and medical affairs at J&J unit Janssen Pharmaceuticals, said the case of anaphylaxis was observed in an ongoing trial of health-care workers in SA.
There had not been any previously reported cases of anaphylaxis, Douoguih said.
She was speaking to a panel of expert advisers to the US Food and Drug Administration which will vote later on whether to recommend authorisation of the vaccine.
Reuters
J&J says two people had severe allergic reactions after Covid-19 shot
The case of anaphylaxis was observed in an ongoing trial of health care workers in SA.
Image: REUTERS/Sandra Sanders
A Johnson & Johnson scientist said on Friday that the company has received preliminary reports of two cases of severe allergic reactions, including one case of anaphylaxis, in people who had received the company's Covid-19 vaccine.
Dr Macaya Douoguih, head of clinical development and medical affairs at J&J unit Janssen Pharmaceuticals, said the case of anaphylaxis was observed in an ongoing trial of health-care workers in SA.
There had not been any previously reported cases of anaphylaxis, Douoguih said.
She was speaking to a panel of expert advisers to the US Food and Drug Administration which will vote later on whether to recommend authorisation of the vaccine.
Reuters
Pfizer Covid-19 vaccine reduces transmission after one dose: UK study
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Trending Now
Latest Videos